In vivo, increased expression of GFI1 in a humanized AML mouse model leads to myeloid differentiation based on immunophenotypical and morphological criteria, increased apoptosis and reduction of cKit+ cells, a fraction, which is enriched for leukemic stem cells in MLL-AF9 associated AML27. This evidence concerns the gene KMT2A and acute myeloid leukemia.